ARYx Therapeutics, Inc. (ARYX)

ARYx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Aug 8, 2025	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Market Capitalization	0	89	79	137	-	-
Market Cap Growth	-99.93%	11.83%	-42.05%	-	-	-
Enterprise Value	-	88	59	228	-	-
Last Close Price	0.00	3.21	2.90	7.75	-	-
PS Ratio	-	-	4.02	32.90	-	-
PB Ratio	-	-30.40	2.89	3.87	-	-
P/TBV Ratio	-	-	2.89	3.87	-	-
EV/Sales Ratio	-	-	3.00	54.79	-	-
Debt / Equity Ratio	-1.50	-3.47	0.50	0.20	0.58	0.78
Net Debt / Equity Ratio	-1.11	-0.81	-1.13	-1.59	-2.38	-1.06
Net Debt / EBITDA Ratio	-0.61	-0.08	1.06	2.02	1.47	0.55
Net Debt / FCF Ratio	-0.43	-0.07	0.68	1.99	7.81	0.58
Asset Turnover	-	-	0.33	0.07	0.11	-
Quick Ratio	0.38	0.89	4.05	4.69	4.36	3.40
Current Ratio	0.47	1.01	4.16	4.82	4.46	3.58
Return on Equity (ROE)	-	-270.76%	-99.48%	-105.40%	-175.00%	-
Return on Assets (ROA)	-74.86%	-61.44%	-31.48%	-28.48%	-39.26%	-
Return on Capital Employed (ROCE)	832.50%	-838.60%	-75.80%	-51.30%	-62.50%	-110.20%
Earnings Yield	-55539393.94%	-37.41%	-39.38%	-20.14%	-	-
FCF Yield	-60972727.27%	-39.60%	-57.85%	-20.61%	-	-
Buyback Yield / Dilution	-17.87%	-44.69%	-466.77%	-228.68%	-11.87%	-6.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.